Vapendavir (diphosphate)

• Description :

  Vapendavir diphosphate (BTA798 diphosphate) is a potent enteroviral capsid binder (CB) . Vapendavir diphosphate (BTA798 diphosphate) possesses potent antiviral activity for enterovirus 71 (EV71) replication, with EC50 values of 0.5-1.4 μM in different EV71 strains[1][2].

• CAS Number :

  [1198151-75-5]

• Product Name Alternative :

  BTA798 (diphosphate)

• UNSPSC :

  12352005

• Target :

  Enterovirus

• Type :

  Reference compound

• Related Pathways :

  Anti-infection

• Applications :

  COVID-19-anti-virus

• Field of Research :

  Infection; Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/vapendavir-diphosphate.html

• Purity :

  98.72

• Solubility :

  DMSO : 6.75 mg/mL (ultrasonic)

• Smiles :

  CCOC1=NOC2=CC(OCCC3CCN(C4=CC=C(C)N=N4)CC3)=CC=C12.OP(O)(O)=O.OP(O)(O)=O

• Molecular Formula :

  C21H32N4O11P2

• Molecular Weight :

  578.45

• References & Citations :

  [1]Tijsma A, et al. The capsid binder Vapendavir and the novel protease inhibitor SG85 inhibit enterovirus 71 replication. Antimicrob Agents Chemother. 2014 Nov;58 (11) :6990-2.|[2]Sun L, et al. Antiviral Activity of Broad-Spectrum and Enterovirus-Specific Inhibitors against Clinical Isolates of Enterovirus D68. Antimicrob Agents Chemother. 2015 Dec;59 (12) :7782-5.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  4°C (Powder, sealed storage, away from moisture)

• Scientific Category :

  Reference compound1

• Clinical Information :

  Phase 2

• Citation 01 :

  Eur J Med Chem. 2025 Feb 14:288:117395.|Norwegian University of Science and Technology. 2023 May.|ACS Infect Dis. 2020 May 8;6 (5) :882-890.|SSRN. 2024 Apr 19.